Vaxcyte, Inc. Business Finance Contracts & Agreements

27 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Vaxcyte, Inc. Form of Warrant to Purchase Common Stock, Dated September 2024
Warrant Agreements
Vaxcyte, Inc.
Biotechnology
NY
2024
Vaxcyte, Inc. Underwriting Agreement for Common Stock and Pre-Funded Warrants (September 2024)
Underwriting Agreements
Vaxcyte, Inc.
Biotechnology
NY
2024
Vaxcyte, Inc. RSU Award Grant Notice and Agreement (2020 Equity Incentive Plan – Non-U.S. Participants)
Equity Distribution Agreements
Vaxcyte, Inc.
Biotechnology
DE
2024
Vaxcyte, Inc. Non-U.S. Stock Option Grant Notice and Agreement (2020 Equity Incentive Plan)
Stock Agreements
Vaxcyte, Inc.
Biotechnology
2024
Vaxcyte, Inc. Warrant to Purchase Common Stock Agreement (February 2024)
Warrant Agreements
Vaxcyte, Inc.
Biotechnology
NY
2024
Vaxcyte, Inc. Underwriting Agreement for Common Stock and Pre-Funded Warrants (January 30, 2024)
Underwriting Agreements
Vaxcyte, Inc.
Biotechnology
NY
2024
Consent to Assignment and First Amendment to Lease Agreement among ARE-San Francisco No. 63, LLC, Codexis, Inc., and Vaxcyte, Inc.
Assignment Agreements
Vaxcyte, Inc.
Biotechnology
2023
Assignment and Assumption of Lease Agreement between Codexis, Inc. and Vaxcyte, Inc. dated September 1, 2023
Assignment Agreements
Vaxcyte, Inc.
Biotechnology
2023
Third Amendment to Amended and Restated SutroVax Agreement between Sutro Biopharma, Inc. and Vaxcyte, Inc.
Modification Agreements
Vaxcyte, Inc.
Biotechnology
2023
Vaxcyte, Inc. Stock Option Grant Notice and Agreement under 2020 Equity Incentive Plan
Equity Distribution Agreements
Vaxcyte, Inc.
Biotechnology
2023
Vaxcyte, Inc. Warrant to Purchase Shares of Common Stock (April 2023)
Warrant Agreements
Vaxcyte, Inc.
Biotechnology
NY
2023
Vaxcyte, Inc. Underwriting Agreement for Common Stock and Pre-Funded Warrants (April 18, 2023)
Underwriting Agreements
Vaxcyte, Inc.
Biotechnology
NY
2023
Amendment No. 1 to Open Market Sale Agreement between Vaxcyte, Inc. and Jefferies LLC
Equity Distribution Agreements
Vaxcyte, Inc.
Biotechnology
2023
Vaxcyte, Inc. Form of Warrant to Purchase Shares of Common Stock, October 2022
Warrant Agreements
Vaxcyte, Inc.
Biotechnology
NY
2022
Vaxcyte, Inc. Underwriting Agreement for Common Stock and Pre-Funded Warrants (October 25, 2022)
Underwriting Agreements
Vaxcyte, Inc.
Biotechnology
NY
2022
Vaxcyte, Inc. RSU Award Grant Notice and Agreement under 2020 Equity Incentive Plan
Equity Distribution Agreements
Vaxcyte, Inc.
Biotechnology
DE
2022
Vaxcyte, Inc. Form of Warrant to Purchase Shares of Common Stock (January 2022)
Warrant Agreements
Vaxcyte, Inc.
Biotechnology
NY
2022
Vaxcyte, Inc. Underwriting Agreement for Common Stock and Pre-Funded Warrants with BofA Securities, Jefferies LLC, and Evercore Group
Underwriting Agreements
Vaxcyte, Inc.
Biotechnology
NY
2022
Description of Capital Stock of Vaxcyte, Inc.
Stock Agreements
Vaxcyte, Inc.
Biotechnology
DE
2021
Vaxcyte, Inc. 2020 Employee Stock Purchase Plan
Equity Distribution Agreements
Vaxcyte, Inc.
Biotechnology
2020
Vaxcyte, Inc. 2020 Equity Incentive Plan
Equity Distribution Agreements
Vaxcyte, Inc.
Biotechnology
DE
2020
Vaxcyte, Inc. Common Stock Certificate
Stock Agreements
Vaxcyte, Inc.
Biotechnology
2020
Vaxcyte, Inc. Underwriting Agreement for Common Stock Offering with BofA Securities, Jefferies LLC, and Evercore Group L.L.C.
Underwriting Agreements
Vaxcyte, Inc.
Biotechnology
NY
2020
Assignment and Assumption of Lease Agreement among Orchard Therapeutics North America, SutroVax, Inc., and Rakesh Kumar and Premila Kumar Revocable Family Trust
Assignment Agreements
Vaxcyte, Inc.
Biotechnology
2020
Pre-IND Payment and Right of First Negotiation Agreement between Lonza Ltd and SutroVax, Inc.
Financing Agreements
Vaxcyte, Inc.
Biotechnology
2020
Vaxcyte, Inc. 2014 Equity Incentive Plan (as Amended and Restated May 24, 2018)
Equity Distribution Agreements
Vaxcyte, Inc.
Biotechnology
DE
2020
Amended and Restated Investors' Rights Agreement between SutroVax, Inc. and Investors (March 20, 2020)
Investor Rights Agreements
Vaxcyte, Inc.
Biotechnology
DE
2020